{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:34:01Z","timestamp":1790771641164,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"PII Oncolog\u00eda Tor\u00e1cica from Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","award":["FIS 12\/02040"],"award-info":[{"award-number":["FIS 12\/02040"]}]},{"name":"PII Oncolog\u00eda Tor\u00e1cica from Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","award":["FIS 12\/02534"],"award-info":[{"award-number":["FIS 12\/02534"]}]},{"name":"PII Oncolog\u00eda Tor\u00e1cica from Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","award":["FIS 12\/01310"],"award-info":[{"award-number":["FIS 12\/01310"]}]},{"name":"E.M. and M.C. from Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca (AGAUR)\u2014Generalitat de Catalunya","award":["2014 GRC-801\/2017 GRC-716"],"award-info":[{"award-number":["2014 GRC-801\/2017 GRC-716"]}]},{"name":"E.M. and M.C. from Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca (AGAUR)\u2014Generalitat de Catalunya","award":["2014 SGR-1017\/2017 SGR-1033"],"award-info":[{"award-number":["2014 SGR-1017\/2017 SGR-1033"]}]},{"name":"ICREA Foundation (ICREA Academia) and MINECO from the Spanish Government and FEDER funds","award":["SAF2014\u201056059\u2010R"],"award-info":[{"award-number":["SAF2014\u201056059\u2010R"]}]},{"name":"ICREA Foundation (ICREA Academia) and MINECO from the Spanish Government and FEDER funds","award":["SAF2015\u201070270\u2010REDT"],"award-info":[{"award-number":["SAF2015\u201070270\u2010REDT"]}]},{"name":"ICREA Foundation (ICREA Academia) and MINECO from the Spanish Government and FEDER funds","award":["SAF2017-89673-R"],"award-info":[{"award-number":["SAF2017-89673-R"]}]},{"name":"European Commission FEDER\u2014Una manera de hacer Europa), and to C.B. from AGAUR-Generalitat de Catalunya"},{"name":"the Instituto de Salud Carlos III and Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas"},{"name":"European Regional Development Fund (ERDF) and CERCA Programme \/ Generalitat de Catalunya"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.lungcan.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,6,10]],"date-time":"2018-06-10T09:40:47Z","timestamp":1528623647000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0242-0274","authenticated-orcid":false,"given":"Laura","family":"Millares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roldan","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Martinez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-5538","authenticated-orcid":false,"given":"Cristina","family":"Balcells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cascante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Belen","family":"Enguita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Rami-Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"S\u00e1nchez de Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Seijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Mons\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2018.06.015_bib0005","unstructured":"WHO Cancer, (n.d.). http:\/\/www.who.int\/mediacentre\/factsheets\/fs297\/en\/."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0010","first-page":"568","article-title":"The impact of the cancer genome atlas on lung cancer","volume":"166","author":"Chang","year":"2015","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/annonc\/mdq361","article-title":"Clinical validation of an autoantibody test for lung cancer","volume":"22","author":"Boyle","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/JTO.0b013e31827627f8","article-title":"Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules","volume":"8","author":"Daly","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0025","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1056\/NEJMoa060476","article-title":"Survival of patients with stage I lung cancer detected on CT screening","volume":"355","author":"International Early Lung Cancer Action Program Investigators","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3892\/ol.2015.3976","article-title":"Role of deregulated microRNAs in non-small cell lung cancer progression using fresh-frozen and formalin-fixed, paraffin-embedded samples","volume":"11","author":"Wang","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0045","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMra0802714","article-title":"Lung cancer","volume":"359","author":"Herbst","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025323","article-title":"Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation","volume":"6","author":"Diaz-Moralli","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0055","doi-asserted-by":"crossref","first-page":"62726","DOI":"10.18632\/oncotarget.10911","article-title":"Oncogenic regulation of tumor metabolic reprogramming","volume":"7","author":"Tarrado-Castellarnau","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0060","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/CAD.0b013e328013d99e","article-title":"The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells","volume":"18","author":"Hu","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0070","first-page":"719","article-title":"Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression","volume":"43","author":"Kayser","year":"2011","journal-title":"Pathology (Phila.)"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.bjc.6602962","article-title":"Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted","volume":"94","author":"Langbein","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0080","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","article-title":"The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer","volume":"6","author":"Bremnes","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0090","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.201508-1545CI","article-title":"Macrophages, inflammation, and lung cancer","volume":"193","author":"Conway","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0105","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2016"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0110","series-title":"UICC TNM Classification of Malignant Tumours","author":"Brierley","year":"2016"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0120","series-title":"IASLC Staging Manual in Thoracic Oncology","year":"2016"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0125","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/JTO.0000000000000334","article-title":"The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer","volume":"9","author":"Rami-Porta","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.arbres.2013.05.002","article-title":"Registro del Grupo Cooperativo de C\u00e1ncer de Pulm\u00f3n-II de la Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica. Estudio descriptivo","volume":"49","author":"S\u00e1nchez de Cos Escu\u00edn","year":"2013","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.arbr.2015.05.005","article-title":"por el Grupo Colaborativo en C\u00e1ncer de Pulm\u00f3n CIBERES-RTICC-SEPAR-Plataforma Biobanco Pulmonar, Biological Marker Analysis as Part of the CIBERES-RTIC Cancer-SEPAR strategic project on lung cancer","author":"Mons\u00f3","year":"2015","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0140","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/JTO.0b013e3181a52370","article-title":"International association for the study of lung cancer International staging committee, the IASLC lung cancer staging project: data elements for the prospective project","volume":"4","author":"Giroux","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0145","unstructured":"Plataforma Biobanco Pulmonar - Bienvenidos a la PBP, (n.d.). http:\/\/biobancopulmonar.ciberes.org\/ (Accessed August 28, 2014)."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0150","doi-asserted-by":"crossref","first-page":"26845","DOI":"10.18632\/oncotarget.15839","article-title":"PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10585-015-9718-1","article-title":"Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation","volume":"32","author":"Ricciardelli","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1525-1438.2007.00799.x","article-title":"Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases","volume":"17","author":"Krockenberger","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1746-1596-3-35","article-title":"TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens","volume":"3","author":"Schultz","year":"2008","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0175","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.oooo.2011.12.022","article-title":"Transketolase-like protein 1 expression in recurrent oral squamous cell carcinoma after curative resection: a case report","volume":"116","author":"Grimm","year":"2013","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0180","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/ijc.24078","article-title":"Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells","volume":"124","author":"Xu","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2007.01.010","article-title":"Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells","volume":"253","author":"Zhang","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopha.2016.11.078","article-title":"Knockdown of TKTL1 additively complements cisplatin-induced cytotoxicity in nasopharyngeal carcinoma cells by regulating the levels of NADPH and ribose-5-phosphate","volume":"85","author":"Dong","year":"2017","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0195","doi-asserted-by":"crossref","first-page":"51875","DOI":"10.18632\/oncotarget.10429","article-title":"A key role for transketolase-like 1 in tumor metabolic reprogramming","volume":"7","author":"Diaz-Moralli","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0200","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12885-016-2185-5","article-title":"Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells","volume":"16","author":"Jayachandran","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1479-5876-4-48","article-title":"Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment","volume":"4","author":"Lewis","year":"2006","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mgene.2013.12.002","article-title":"Association of interleukin 1 beta (IL-1\u03b2) polymorphism with mRNA expression and risk of non small cell lung cancer","volume":"2","author":"Bhat","year":"2014","journal-title":"Meta Gene"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0215","first-page":"3500","article-title":"The role of IL-1\u03b2 in the early tumor cell-induced angiogenic response","volume":"190","author":"Carmi","year":"2013","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.lungcan.2018.06.015_bib0220","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI23298","article-title":"Infiltration of COX-2\u2013expressing macrophages is a prerequisite for IL-1\u03b2\u2013induced neovascularization and tumor growth","volume":"115","author":"Nakao","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0225","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2011.12.005","article-title":"Cancer-related inflammation: common themes and therapeutic opportunities","volume":"22","author":"Balkwill","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0230","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/jnci\/djm083","article-title":"Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier","volume":"99","author":"Seike","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0235","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1517\/14712598.2015.1071348","article-title":"Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?","volume":"15","author":"Passiglia","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0240","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00428-016-1910-4","article-title":"Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients","volume":"468","author":"Ilie","year":"2016","journal-title":"Virchows Arch."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0245","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(16)31340-X","article-title":"Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease","volume":"388","author":"Hiley","year":"2016","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.lungcan.2018.06.015_bib0250","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218304240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218304240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:29:51Z","timestamp":1759235391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218304240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"alternative-id":["S0169500218304240"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.06.015","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-associated metabolic and inflammatory responses in early stage non-small cell lung cancer: Local patterns and prognostic significance","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}